Region 3 Program: Beyond the Scales: Cardiometabolic Benefits of Today’s Anti-Obesity Agents
Participants will examine the evolving landscape of obesity pharmacotherapy with a spotlight on the cardiovascular implications of modern anti-obesity medications. The session will review current and emerging agents, summarize key... Read more »